Literature DB >> 19062213

One-dimensional cellulose acetate plate electrophoresis--a feasible method for analysis of dermatan sulfate and other glycosaminoglycan impurities in pharmaceutical heparin.

Rainer Domanig1, Wolfgang Jöbstl, Silvia Gruber, Thomas Freudemann.   

Abstract

A cellulose acetate plate electrophoresis method for analysis of pharmaceutical heparin and its potential glycosaminoglycan impurities, e.g. dermatan sulfate, chondroitin sulfate and oversulfated chondroitin sulfate, is presented. Heparin is chemically degraded by application of nitrous acid and residual glycosaminoglycans are electrophoretically separated thereafter. After staining using Alcian blue 8GS, these glycosaminoglycan impurities can be quantified by means of comparison to a dermatan sulfate standard. Results of a validation study of this analytical method are shown, demonstrating its feasibility for routine use in analytical quality control labs under GMP conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19062213     DOI: 10.1016/j.jpba.2008.10.017

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Mass balance analysis of contaminated heparin product.

Authors:  Zhenling Liu; Zhongping Xiao; Sayaka Masuko; Wenjing Zhao; Eric Sterner; Vinod Bansal; Jawed Fareed; Jonathan Dordick; Fuming Zhang; Robert J Linhardt
Journal:  Anal Biochem       Date:  2010-09-17       Impact factor: 3.365

2.  Electrospun cellulose acetate membrane for size separating and antibacterial screening of crude polysaccharides.

Authors:  Jiraporn Chumpol; Sineenat Siri
Journal:  IET Nanobiotechnol       Date:  2016-12       Impact factor: 1.847

3.  Isolation and Characterization of a Heparin-Like Compound with Potent Anticoagulant and Fibrinolytic Activity from the Clam Coelomactra antiquata.

Authors:  ZhenXing Du; XueJing Jia; Jing Chen; SiYi Zhou; JianPing Chen; XiaoFei Liu; XiaoHuang Cao; SaiYi Zhong; PengZhi Hong
Journal:  Mar Drugs       Date:  2019-12-19       Impact factor: 5.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.